pentobarbital decreases outcomes of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Carefully. Coadministration of CYP3A4 inducers may minimize sufentanil degrees and efficacy, potentially precipitating withdrawal syndrome in individuals who may have cr